Recurrent/Metastatic Gastric Cancer

3 clinical trials · Condition

Record	Firm	Date
Study of M7824 and Paclitaxel Combination as a Second-line Treatment in Patients With Recurrent/Metastatic Gastric Cancer (NCT04835896)	Yonsei University	2021-06-02
Study of Ramucirumab, Trastuzumab and Paclitaxel in Patients With HER2-positive Recurrent/Metastatic Gastric Cancer (HER-RAM Study) (NCT04888663)	Yonsei University	2018-02-13
Phase Ib/II Study to Evaluate the Safety and Efficacy of Nivolumab in Combination With Paclitaxel in Epstein-Barr Virus(EBV)-Related, or Microsatellite Instability-High (MSI-H), or Programmed Cell Death Ligand 1 (PD-L1) Positive Advanced Gastric Cancer (NCT05535569)	Yonsei University	2017-07-17

Every clearance here is in the API, with alerts when new ones post.